Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees

Journal of General Virology

Volumn 79, Issue 12, 1998, Pages 2895-2903

  Bogers, W M J M ^a   Koornstra, W H ^a   Dubbes, R H ^a   Ten Haaft, P J F ^a   Verstrepen, B E ^a   Jhagjhoorsingh, S S ^a   Haaksma, A G M ^a   Niphuis, H ^a   Laman, J D ^b   Norley, S ^c   Schuitemaker, H ^d   Goudsmit, J ^e   Hunsmann, G ^f   Heeney, J L ^a   Wigzell, H ^g  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c PAUL EHRLICH INSTITUT   (Germany)

^d CENTRAL LABORATORY   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f GERMAN PRIMATE CENTER   (Germany)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHIMPANZEE; CONSENSUS SEQUENCE; CYTOPATHOGENIC EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE CELL; MONONUCLEAR CELL; NONHUMAN; PLASMA; POLYMERASE CHAIN REACTION; PRIMARY INFECTION; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PAN (APE); PAN TROGLODYTES; RNA VIRUSES; TROGLODYTES;

EID: 0032422169     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-12-2895     Document Type: Article

References (7)

1. Arthur, L. O., Bess, J., Jr, Waters, D. J., Pyle, S. W., Kelliher, J. C., Nara, P. L., Krohn, K., Robey, W. G., Langlois, A. J. & Gallo, R. C. (1989). Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. Journal of Virology 63, 5046-5053.
2. Berman, P. W., Groopman, J. E., Gregory, T., Clapham, P. R., Weiss, R. A., Ferriani, R., Riddle, L., Shimasaki, C., Lucas, C. & Lasky, L. A. (1988). Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. Proceedings of the National Academy of Sciences, USA 85, 5200-5204.
3. Bogers, W. M., Dubbes, R., ten Haaft, P., Niphuis, H., Cheng-Mayer, C., Stahl-Hennig, C., Hunsmann, G., Kuwata, T., Hayami, M., Jones, S., Ranjbar, S., Almond, N., Stott, J., Rosenwirth, B. & Heeney, J. L. (1997a). Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology 236, 110-117.
4. Bogers, W. M., Koornstra, W. H., Dubbes, R. H., Nara, P., Buijs, L. & Heeney, J. L. (1997b). Potent HIV-I inhibiting soluble factor from chimpanzee peripheral blood cells. In Research in HIV and Cytokines, pp. 211-215. Edited by M. Guenounou. Paris: Inserm.
5. Bruck, C., Thiriart, C., Fabry, L., Francotte, M., Pala, P., Van Opstal, O., Culp, J., Rosenberg, M., De Wilde, M., Heidt, P. & Heeney, J. L. (1994). HIV-1 envelope-elicited neutralizing antibody litres correlate with protection and virus load in chimpanzees. Vaccine 12, 1141-1148.
6. Girard, M., Kieny, M. P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., Muchmore, E. & Fultz, P. (1991). Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 88, 542-546.
7. Zhang, L., Huang, Y., He, T., Cao, Y. & Ho, D. D. (1996). HIV-1 subtype and second-receptor use. Nature 383, 768.